A study conducted at Wuhan Hospital in China has shown that patients with advanced cancer seem to be more vulnerable to COVID-19 than those without. The multicentre study published in Cancer Discovery last month recruited 105 cancer patients and 536 age-matched non-cancer patients, all confirmed with COVID-19 from 14 hospitals in Wuhan. Patients with cancer […]
A recent study published in the journal Cancer last month compared the survival of 8,988 kidney cancer patients from the American National Cancer Data Base to assess the impact of cancer spread to the lymph nodes in patients with stage III renal cell carcinoma (RCC). The researchers found that the 5-year survival rate of patients […]
This study describes patient-reported outcomes from the phase 3 IMmotion151 study to assess the safety and efficacy of atezolizumab in combination with bevacizumab in patients with untreated metastatic renal cell carcinoma (RCC) and who were positive for the PD-L1 biomarker. In this study, the patients treated with atezolizumab plus bevacizumab had longer progression-free survival compared […]
A recent letter in Metro highlights the difficulties facing cancer patients with the government guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. The letter describes a stage four kidney cancer patient who is on treatment that renders him vulnerable to coronavirus infection. His family think he should be on the […]
Patients who are most at risk of severe complications from COVID-19 have been asked to ‘shield’ themselves. This means that they should stay at home and avoid face-to-face contact with anyone from outside of their household. In addition, members of their household are advised to stringently follow social distancing rules. GP practices have a key […]
The government have issued a set of frequently asked questions about what you can and can’t do during the coronavirus outbreak: Coronavirus outbreak FAQs: what you can and can’t do
Around half of all cases of renal cell carcinoma (RCC) are incidentally diagnosed on imaging as small renal masses, clinical stage T1a and smaller than 4 cm. Around 30% of small renal masses are found to be benign. The management of small renal masses is under debate, including whether a biopsy should be performed for […]
In this interview, Professor Thomas Powles from Barts Cancer Institute in London joins Alicia Morgans in a follow-up discussion providing an update to a previously recorded conversation on the current healthcare environment during the coronavirus (COVID-19) pandemic in the United Kingdom. Prof Powles shares an aspirational perspective from London looking towards the future in terms […]
Are you self-isolating and in need of support? Find out more about how an NHS Volunteer Responder can help you. We know that some kidney cancer patients have not received a letter to inform them that they are at the highest clinical risk from coronavirus (COVID-19) and they are extremely vulnerable. However, these people are experiencing problems […]
The NHS has launched a major new drive to persuade the public to seek the urgent care and treatment they need and that, despite COVID-19, the NHS is open for business. Delays in getting treatment due to coronavirus fears pose a long term risk to people’s health. In addition, fewer people are going to their […]
Copyright 2017 Kidney Cancer Support Network- Douglass Digital | Cambridge Web Design
